CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

How Cloudbased Lims Helps Cros

How Cloudbased Lims Helps Cros

MMS Holdings Announces New Pro-Bono Support Program

MMS Holdings Announces New Pro-Bono...

Syneos Health and Science 37 Announce Strategic Partnership

Syneos Health and Science 37 Announce...

Inotiv Secures MilliporeSigmas BioReliance Genetic Toxicology Assets

Inotiv Secures MilliporeSigmas...

Avance Appoints New Business Development Manager APAC

Avance Appoints New Business...

The Growing Demand for Contract Research Organizations

The Growing Demand for Contract...

The Potential for Artificial Intelligence in Clinical Trials

The Potential for Artificial...

Craig Lipset Joins Member and Executive Advisor of MedVector

Craig Lipset Joins Member and...

How Cloudbased Lims Helps Cros

How Cloudbased Lims Helps Cros

MMS Holdings Announces New Pro-Bono Support Program

MMS Holdings Announces New Pro-Bono...

Syneos Health and Science 37 Announce Strategic Partnership

Syneos Health and Science 37 Announce...

Inotiv Secures MilliporeSigmas BioReliance Genetic Toxicology Assets

Inotiv Secures MilliporeSigmas...

Avance Appoints New Business Development Manager APAC

Avance Appoints New Business...

The Growing Demand for Contract Research Organizations

The Growing Demand for Contract...

The Potential for Artificial Intelligence in Clinical Trials

The Potential for Artificial...

Craig Lipset Joins Member and Executive Advisor of MedVector

Craig Lipset Joins Member and...

Lixte Biotechnology Holdings Welcomes Gil N Schwartzberg

Life Sciences Review Life Sciences Review | Wednesday, April 28, 2021
Tweet

Gil N Schwartzberg comes to Lixte Biotechnology Holdings.


FREMONT, CA: Lixte Biotechnology Holdings, a clinical-stage drug discovery firm that is developing pharmacologically active drugs for use in cancer treatment announces Gil N Schwartzberg's appointment to its Board of Directors. Mr. Schwartzberg is filling a vacancy generated by the resignation of Winson (Sze Chun) Ho, M.D. Gil Schwartzberg has played an essential role in advising and helping Lixte since its inception. The company is pleased to be welcoming Mr. Schwartzberg to the Board of Directors.


Dr. Ho leaves the Lixte Board of Directors to focus his expertise on clinical and pre-clinical cancer research in academic medicine. Dr. Ho has led Lixte with distinction, and the company wishes him great success in his future endeavors.


Gil N Schwartzberg has been a consultant to Lixte since its founding. Previously, Mr. Schwartzberg was Chairman of the Board, President, and CEO of the City of Hope National Medical Center, a leading biomedical research and treatment facilities and an NCI Comprehensive Cancer Center. Mr. Schwartzberg is a person in the hundred-plus-year history of the City of Hope to have led as both Chairman of the Board and CEO. Mr. Schwartzberg is City of Hope Chairman Emeritus for life now.


Before joining the City of Hope, Mr. Schwartzberg was Vice Chairman of the Board of Directors of Sterling Bank of Los Angeles, of which he was a founder, and where he served for several years as the Chairman of the Loan Committee until the banks' sale. Besides, Mr. Schwartzberg was a founding shareholder of Skechers USA, Inc. Mr. Schwartzberg is a consultant to Skechers and both trustee and co-trustee of trusts that hold the controlling interest in Skechers.


Mr. Schwartzberg secured a Juris Doctorate awarded magna cum laude. Mr. Schwartzberg practiced law, specializing in business structure and transactions, and is a member in good standing of the California Bar. Mr. Schwartzberg is the author of books like Warning! Toxic Business Mistakes and How to Avoid Making Them and Jane Austen's Persuasion Annotated, a Royal Navy Reading Companion.


Weekly Brief

loading
Top 10 CROs - 2021
> <
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue

Read Also

Everything You Need to Know About Medical Lab Equipment and their Applications

Everything You Need to Know About Medical Lab Equipment and their Applications

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial

How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

The several benefits Of Agricultural Genome Editing

The several benefits Of Agricultural Genome Editing
Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks To Buy In 2022

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/lixte-biotechnology-holdings-welcomes-gil-n-schwartzberg-nwid-341.html